102 related articles for article (PubMed ID: 16164489)
1. Dose evaluation for long-term magnesium treatment in aneurysmal subarachnoid haemorrhage.
van Norden AG; van den Bergh WM; Rinkel GJ
J Clin Pharm Ther; 2005 Oct; 30(5):439-42. PubMed ID: 16164489
[TBL] [Abstract][Full Text] [Related]
2. Magnesium therapy after aneurysmal subarachnoid haemorrhage a dose-finding study for long term treatment.
van den Bergh WM; Albrecht KW; Berkelbach van der Sprenkel JW; Rinkel GJ
Acta Neurochir (Wien); 2003 Mar; 145(3):195-9; discussion 199. PubMed ID: 12632115
[TBL] [Abstract][Full Text] [Related]
3. The effect of intravenous magnesium therapy on serum and urine levels of potassium, calcium, and sodium in patients with ischemic heart disease, with and without acute myocardial infarction.
Rasmussen HS; Cintin C; Aurup P; Breum L; McNair P
Arch Intern Med; 1988 Aug; 148(8):1801-5. PubMed ID: 3041940
[TBL] [Abstract][Full Text] [Related]
4. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
Schmid-Elsaesser R; Kunz M; Zausinger S; Prueckner S; Briegel J; Steiger HJ
Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884
[TBL] [Abstract][Full Text] [Related]
5. Magnesium sulfate in the management of patients with aneurysmal subarachnoid hemorrhage: a randomized, placebo-controlled, dose-adapted trial.
Muroi C; Terzic A; Fortunati M; Yonekawa Y; Keller E
Surg Neurol; 2008 Jan; 69(1):33-9; discussion 39. PubMed ID: 18054611
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the efficacy and safety of intravenous conivaptan in patients with euvolaemic hyponatraemia: subgroup analysis of a randomized, controlled study.
Verbalis JG; Zeltser D; Smith N; Barve A; Andoh M
Clin Endocrinol (Oxf); 2008 Jul; 69(1):159-68. PubMed ID: 18034777
[TBL] [Abstract][Full Text] [Related]
7. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
8. Effect of magnesium treatment and glucose levels on delayed cerebral ischemia in patients with subarachnoid hemorrhage: a substudy of the Magnesium in Aneurysmal Subarachnoid Haemorrhage trial (MASH-II).
Leijenaar JF; Dorhout Mees SM; Algra A; van den Bergh WM; Rinkel GJ;
Int J Stroke; 2015 Oct; 10 Suppl A100():108-12. PubMed ID: 26502971
[TBL] [Abstract][Full Text] [Related]
9. Erythropoietin in patients with aneurysmal subarachnoid haemorrhage: a double blind randomised clinical trial.
Springborg JB; Møller C; Gideon P; Jørgensen OS; Juhler M; Olsen NV
Acta Neurochir (Wien); 2007 Nov; 149(11):1089-101; discussion 1101. PubMed ID: 17876497
[TBL] [Abstract][Full Text] [Related]
10. Hypocalcaemia may reduce the beneficial effect of magnesium treatment in aneurysmal subarachnoid haemorrhage.
Van de Water JM; Van den Bergh WM; Hoff RG; Algra A; Rinkel GJ
Magnes Res; 2007 Jun; 20(2):130-5. PubMed ID: 18062586
[TBL] [Abstract][Full Text] [Related]
11. Effect of exenatide on 24-hour blood glucose profile compared with placebo in patients with type 2 diabetes: a randomized, double-blind, two-arm, parallel-group, placebo-controlled, 2-week study.
Schwartz SL; Ratner RE; Kim DD; Qu Y; Fechner LL; Lenox SM; Holcombe JH
Clin Ther; 2008 May; 30(5):858-67. PubMed ID: 18555933
[TBL] [Abstract][Full Text] [Related]
12. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
[TBL] [Abstract][Full Text] [Related]
13. Achieved serum magnesium concentrations and occurrence of delayed cerebral ischaemia and poor outcome in aneurysmal subarachnoid haemorrhage.
Dorhout Mees SM; van den Bergh WM; Algra A; Rinkel GJ
J Neurol Neurosurg Psychiatry; 2007 Jul; 78(7):729-31. PubMed ID: 17135457
[TBL] [Abstract][Full Text] [Related]
14. Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trial.
Dorhout Mees SM; Algra A; Vandertop WP; van Kooten F; Kuijsten HA; Boiten J; van Oostenbrugge RJ; Al-Shahi Salman R; Lavados PM; Rinkel GJ; van den Bergh WM;
Lancet; 2012 Jul; 380(9836):44-9. PubMed ID: 22633825
[TBL] [Abstract][Full Text] [Related]
15. Magnesium and headache after aneurysmal subarachnoid haemorrhage.
Dorhout Mees SM; Bertens D; van der Worp HB; Rinkel GJ; van den Bergh WM
J Neurol Neurosurg Psychiatry; 2010 May; 81(5):490-3. PubMed ID: 19828484
[TBL] [Abstract][Full Text] [Related]
16. Effects of oral magnesium supplementation on glycaemic control in Type 2 diabetes: a meta-analysis of randomized double-blind controlled trials.
Song Y; He K; Levitan EB; Manson JE; Liu S
Diabet Med; 2006 Oct; 23(10):1050-6. PubMed ID: 16978367
[TBL] [Abstract][Full Text] [Related]
17. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
van den Bergh WM; Mees SM; Rinkel GJ
Neurosurgery; 2006 Nov; 59(5):E1152; author reply E1152. PubMed ID: 17143226
[No Abstract] [Full Text] [Related]
18. Biologic effects of simvastatin in patients with aneurysmal subarachnoid hemorrhage: a double-blind, placebo-controlled randomized trial.
Vergouwen MD; Meijers JC; Geskus RB; Coert BA; Horn J; Stroes ES; van der Poll T; Vermeulen M; Roos YB
J Cereb Blood Flow Metab; 2009 Aug; 29(8):1444-53. PubMed ID: 19458605
[TBL] [Abstract][Full Text] [Related]
19. Pilot randomised double-blind controlled trial of high-dose spironolactone in critically ill patients receiving a frusemide infusion.
Apte Y; Bellomo R; Warrillow S; Goldsmith D; Gillies M; McGain F
Crit Care Resusc; 2008 Dec; 10(4):306-11. PubMed ID: 19049481
[TBL] [Abstract][Full Text] [Related]
20. Magnesium sulphate in the management of patients with aneurysmal subarachnoid haemorrhage: a meta-analysis of prospective controlled trials.
Ma L; Liu WG; Zhang JM; Chen G; Fan J; Sheng HS
Brain Inj; 2010; 24(5):730-5. PubMed ID: 20334471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
